These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23559891)

  • 41. Sober living houses: potential roles in substance abuse services and suggestions for research.
    Polcin DL
    Subst Use Misuse; 2001 Feb; 36(3):301-11. PubMed ID: 11325168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.
    Salo R; Fassbender C; Iosif AM; Ursu S; Leamon MH; Carter C
    Psychiatry Res; 2013 Dec; 210(2):529-35. PubMed ID: 23896355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Review of Risk Factors for Methamphetamine-Related Psychiatric Symptoms.
    Chang X; Sun Y; Zhang Y; Muhai J; Lu L; Shi J
    Front Psychiatry; 2018; 9():603. PubMed ID: 30519197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
    Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
    BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gender differences in the behavioral and subjective effects of methamphetamine in healthy humans.
    Mayo LM; Paul E; DeArcangelis J; Van Hedger K; de Wit H
    Psychopharmacology (Berl); 2019 Aug; 236(8):2413-2423. PubMed ID: 31165207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of life among treatment seeking methamphetamine-dependent individuals.
    Gonzales R; Ang A; Glik DC; Rawson RA; Lee S; Iguchi MY;
    Am J Addict; 2011; 20(4):366-72. PubMed ID: 21679268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurocognitive deficits are associated with unemployment in chronic methamphetamine users.
    Weber E; Blackstone K; Iudicello JE; Morgan EE; Grant I; Moore DJ; Woods SP;
    Drug Alcohol Depend; 2012 Sep; 125(1-2):146-53. PubMed ID: 22560676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is hepatitis C infection associated with increased risk of depression in persons with methamphetamine dependence?
    Vigil O; Woods SP; Moran LM; Letendre SL; Young-Casey C; Grant I; Atkinson JH
    Am J Addict; 2007; 16(5):418-23. PubMed ID: 17882614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.
    Alexander PD; Gicas KM; Willi TS; Kim CN; Boyeva V; Procyshyn RM; Smith GN; Thornton AE; Panenka WJ; Jones AA; Vila-Rodriguez F; Lang DJ; William MacEwan G; Honer WG; Barr AM
    Psychopharmacology (Berl); 2017 May; 234(9-10):1535-1547. PubMed ID: 28190084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants.
    Mahoney JJ; Kalechstein AD; De La Garza R; Newton TF
    Am J Addict; 2008; 17(2):83-98. PubMed ID: 18393050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recovery Home Environment Characteristics Associated with Recovery Capital.
    Polcin DL; Mahoney E; Witbrodt J; Mericle AA
    J Drug Issues; 2020 Apr; 51(2):253-267. PubMed ID: 34650312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment.
    Lecomte T; Mueser KT; MacEwan W; Thornton AE; Buchanan T; Bouchard V; Goldner E; Brink J; Lang D; Kang S; Barr AM; Honer WG
    J Nerv Ment Dis; 2013 Dec; 201(12):1085-9. PubMed ID: 24284645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A model for sober housing during outpatient treatment.
    Polcin DL
    J Psychoactive Drugs; 2009 Jun; 41(2):153-61. PubMed ID: 19705677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sober living house characteristics: A multilevel analyses of factors associated with improved outcomes.
    Mericle AA; Mahoney E; Korcha R; Delucchi K; Polcin DL
    J Subst Abuse Treat; 2019 Mar; 98():28-38. PubMed ID: 30665601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
    Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
    J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
    [No Abstract]   [Full Text] [Related]  

  • 56. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence.
    Iudicello JE; Woods SP; Vigil O; Scott JC; Cherner M; Heaton RK; Atkinson JH; Grant I;
    J Clin Exp Neuropsychol; 2010 Aug; 32(7):704-18. PubMed ID: 20198527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlates of rural methamphetamine and cocaine users: results from a multistate community study.
    Booth BM; Leukefeld C; Falck R; Wang J; Carlson R
    J Stud Alcohol; 2006 Jul; 67(4):493-501. PubMed ID: 16736068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measuring Architecture in Recovery Homes: Recovery Home Architecture Scale.
    Polcin DL; Mahoney E; Witbrodt J; Mericle AA; Subbaraman M; Wittman FD
    Subst Use Misuse; 2023; 58(1):103-110. PubMed ID: 36437776
    [No Abstract]   [Full Text] [Related]  

  • 59. Elevated neurobehavioral symptoms are associated with everyday functioning problems in chronic methamphetamine users.
    Cattie JE; Woods SP; Iudicello JE; Posada C; Grant I;
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):331-9. PubMed ID: 23037647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Misremembering future intentions in methamphetamine-dependent individuals.
    Iudicello JE; Weber E; Grant I; Weinborn M; Woods SP;
    Clin Neuropsychol; 2011 Feb; 25(2):269-86. PubMed ID: 21331980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.